Variables | All-cause mortality at 2.5 years | |||||
---|---|---|---|---|---|---|
Young adults 20–34 years old 20–34 years old (n = 92; 36%) | Adults 35–45 years old 35–45 years old (n = 167; 64%) | |||||
HR | 95% CI | p value | HR | 95% CI | p value | |
Males | 0.095 | 0.007–1.240 | 0.273 | 1.135 | 0.299–4.310 | 0.852 |
Chronic kidney disease | 1.064 | 0.090–1.064 | 0.961 | 2.492 | 0.822–7.553 | 0.106 |
LVEF < 35% | 33.590 | 2.395–471.404 | 0.009 | 2.296 | 0.822–7.553 | 0.164 |
AMI | 2.073 | 0.149–28.910 | 0.588 | 1.053 | 0.364–3.047 | 0.924 |
Atrial fibrillation | 11.090 | 0.618–199.219 | 0.102 | 1.469 | 0.364–3.047 | 0.459 |
Ventricular fibrillation | 3.840 | 0.322–44.354 | 0.281 | 2.975 | 0.904–9.796 | 0.073 |
Variables | Composite endpoint at 2.5 years (cardiac death at 24 h, recurrent ventricular tachyarrhythmias, appropriate ICD therapies) | |||||
---|---|---|---|---|---|---|
Young adults 20–34 years old | Adults 35–45 years old | |||||
HR | 95% CI | p value | HR | 95% CI | p value | |
Males | 0.526 | 0.179–1.543 | 0.242 | 0.763 | 0.278–2.095 | 0.599 |
Chronic kidney disease | 1.349 | 0.368–5.025 | 0.645 | 1.532 | 0.539–4.351 | 0.423 |
LVEF < 35% | 0.894 | 0.114–7.013 | 0.915 | 1.739 | 0.594–5.096 | 0.313 |
AMI | 0.830 | 0.084–8.198 | 0.873 | 0.741 | 0.234–2.349 | 0.611 |
Atrial fibrillation | 1.354 | 0.165–11.127 | 0.778 | 0.995 | 0.348–2.848 | 0.922 |
Ventricular fibrillation | 0.443 | 0.105–1.875 | 0.296 | 0.765 | 0.293–1.999 | 0.584 |